Focused insights: Data implications of ADCs in NSCLC treatment

touchFOCUS for touchONCOLOGY

Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.

The expert

• Prof. Céline Mascaux, Strasbourg University, Strasbourg, France

This touchPODCAST is for HCPs only

This activity is funded by an independent medical education grant from AstraZeneca.

This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website:
www.touchoncology.org/ADCs-in-NSCLC